Plus   Neg

SAP Unveils Blockchain Project To Help Eliminate Counterfeit Drugs


German software giant SAP SE announced the launch of its blockchain-based supply chain tracking system that helps eliminate counterfeit drugs along the pharmaceutical supply chain.

In a statement, the company noted that its blockchain-based solution helps customers comply with the U.S. Drug Supply Chain Security Act or DSCSA. The legislation requires that by November 2019 wholesalers verify prescription drugs that are returned and intended for resale. The motive behind the act is to protect consumers from fake, contaminated and stolen medication.

SAP Information Collaboration Hub for Life Sciences, option for U.S. supply chain, a blockchain-technology hub, is designed to authenticate pharmaceutical packaging returned from hospitals and pharmacies to wholesalers before products are resold.

The new software helps customers to verify the product code, lot, expiration date and a unique serial number embedded in the barcode against manufacturers' data stored in the blockchain.

For the software development, the company has joined with AmerisourceBergen, Boehringer Ingelheim AG & Co. KG, GlaxoSmithKline plc and Merck Sharp & Dohme, among others.

In the US, drug wholesalers handle nearly 60 million returns annually, accounting for an estimated $7 billion. These drugs usually are resold to the public regardless of their conditions.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT